University of Cambridge
304
54
72
132
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
3.6%
11 terminated/withdrawn out of 304 trials
92.3%
+5.8% vs industry average
9%
26 trials in Phase 3/4
12%
16 of 132 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (304)
Physical Activity in Schools After the Reform
Role: collaborator
A Smartphone Based Intervention for the Prevention of Relapse in Alcohol Dependence
Role: collaborator
Investigating Cognitive Flexibility Training
Role: collaborator
Children's Health in London and Luton (CHILL)
Role: collaborator
Metabolic Phenotyping in vEDS
Role: collaborator
BEARS Training Package to Maximise Hearing Abilities in Older Children and Teenagers With Bilateral Cochlear Implants
Role: collaborator
Cardiovascular Acoustics for Early Disease Detection
Role: collaborator
Population Based Germline Testing for Early Detection and Prevention of Cancer
Role: collaborator
Personalized Breast Cancer Screening
Role: collaborator
Deep Brain Stimulation to Understand and Treat Addiction
Role: lead
An Adaptive Multi-arm Trial to Improve Clinical Outcomes Among Children Recovering From Complicated SAM
Role: collaborator
Ultrafast Whole Genome Sequencing for Childhood Cancer
Role: lead
Closed-loop in Adults With Type 2 Diabetes
Role: lead
Effect of infLuenza vaccInation After Myocardial INfArction on Cardiac inflammaTory responsE
Role: collaborator
A Trial to Test the Use of Dapansutrile, an Anti-inflammatory Medication, in People With Parkinson's Disease
Role: collaborator
Closed-loop for People Living With Cystic Fibrosis Related Diabetes
Role: lead
UK CARDIOvascular Immune-Mediated Inflammatory Diseases (CARDIO-IMID) Registry Study
Role: collaborator
Duroplasty for Injured Cervical Spinal Cord With Uncontrolled Swelling
Role: collaborator
5G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours
Role: collaborator
AGILE (Early Phase Platform Trial for COVID-19)
Role: collaborator